Creating simulated brain scans for alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study uses artificial intelligence to create a simulated FDG PET brain scan from an amyloid PET scan. This could help doctors monitor Alzheimer's disease without needing an extra scan, making diagnosis and tracking easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years of age or older.
- You must have had an amyloid PET scan (with Florbetaben or Flutemetamol) sometime between January 1 and December 31, 2025.
- You must also have had a brain MRI and a standard FDG PET scan within 6 months of that amyloid PET scan.
- All three scans must be of good quality, without distortion or technical issues.
- You cannot have other major brain disorders like Parkinson's disease, frontotemporal dementia, a brain tumor, or a recent stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special PET brain scans to look at proteins linked to Alzheimer's disease, which may help diagnose it and track how it changes over time.
This study tests a new PET imaging agent called [18F]F-AraG to see if it can help spot changes in the brain linked to Alzheimer's disease. The trial is for people who may have Alzheimer's and uses a special scan to look for signs of inflammation or other immune activity in the brain.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
This study uses brain imaging to measure two things in the brain—amyloid protein and how the brain uses sugar. It may help researchers better understand early brain changes in people in the ALFA project.
This trial uses special PET scans to see amyloid and tau proteins in the brain, which are linked to Alzheimer's. It aims to find these changes early, in people with mild memory problems or early-stage Alzheimer's.
This extension study looks for predictors—measurable clues—linked to memory changes in older adults who feel their memory is worsening. You may be asked to have an amyloid PET scan, which can help researchers understand what might be driving memory concerns.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.